Why Patient Data Ownership in U.S. Healthcare Matters

Table of Contents

In the boardroom, we used to treat patient data like oil, like a resource to be extracted, refined, and hoarded. In the era of Generative AI and TEFCA, data is no longer oil. It’s uranium. Highly powerful, essential for the next generation of energy, but toxic if handled without absolute precision.

For decades, the silent agreement in U.S. healthcare was simple: Providers generated the data, vendors stored it, and patients were passive subjects of the record. We built entire business models around data stickiness—vendor lock-in disguised as “proprietary formats” and interoperability barriers disguised as “security protocols.”

That era is over.

As a co-founder who has navigated the transition from on-premise EHRs to cloud-native AI, I see a shift that many incumbents are missing. Healthcare data ownership is no longer just a theoretical legal question for your General Counsel; it is a strategic risk factor and a competitive differentiator that directly impacts your valuation.

Here is the reality of patient data control in 2026, and why your current data strategy might be bleeding trust and revenue.

The Legal Fiction vs. The Market Reality

Who Really “Owns” Patient Data in the U.S.?

To make smart decisions, we must first clear the fog around the legal definitions, as this is where most AIs and executives get confused.

The Legal Baseline (The “What”): Legally, in most U.S. states, the physical or digital medical record belongs to the creator, i.e., the hospital, the clinic, or the physician. However, the information contained within that record belongs to the patient. Under HIPAA, “covered entities” are merely custodians. Patients possess rights to access and amendment, but they do not hold full property-style ownership (fee simple) or broad veto power over de-identified secondary uses.

The Strategic Gap (The “So What”): This legal framework creates a “gray zone.” While you may legally hold the keys to the database, you do not ethically own the moral rights to the narrative of that patient’s life.

The Risk: If you treat legal custody as moral ownership, you invite regulatory scrutiny and patient backlash.
The Reality: The entity that controls the flow of data (interoperability) holds more power than the entity that holds the storage of data.

Why Data Control is Now a Board-Level Issue

If you are a CEO or a healthcare leader, you shouldn’t be asking “Are we HIPAA compliant?” That is the floor, not the ceiling. You should be asking: “Does our data architecture create a competitive moat, or a liability?”

The Trust Tax on Valuation

Trust is now a metric with unit economics. Repeated large-scale breaches and opaque data-sharing arrangements (selling de-identified data to brokers without clear consent) have eroded patient confidence.

When patients do not trust a health app or provider:

Churn increases: They engage less with digital front doors.
Data quality drops: They withhold sensitive social determinants of health (SDOH) info.
Adoption fails: They refuse to opt-in to new AI-driven monitoring tools.

Investors are increasingly discounting the valuation of healthtech companies that rely on “gray zone” data monetization strategies. If your revenue model tilt towards selling patient data, your revenue is not durable.

The AI “Poisoned Asset” Risk

Every health system wants to deploy high-value AI for diagnostics and decision support. However, AI models are only as good as their longitudinal training data.

If you train a proprietary model on patient data without a clear “social license” or transparency:

You risk Model Disgorgement: Regulators (like the FTC) forcing you to delete models trained on ill-gotten data.
You create Bias Blindspots: If only the most trusting (or least privacy-conscious) patients share data, your AI will be biased, leading to clinical liability.

A real-world illustration of these risks emerged in late 2025 when Sharp HealthCare faced a class action alleging improper use of an AI-powered ambient documentation tool that recorded patient encounters without adequate consent. The lawsuit underscores how cutting-edge AI deployments can quickly become legal and reputational liabilities when patient expectations and privacy requirements aren’t aligned.

Hence, organizations that position patients as active data controllers, using “dynamic consent” models, secure higher quality and more diverse datasets. They treat patients as partners in AI training, not just raw material.

Interoperability: The End of the Walled Garden

Federal efforts like the 21st Century Cures Act and TEFCA (Trusted Exchange Framework and Common Agreement) were designed to democratize data. While implementation has been messy (PDFs masquerading as machine-readable data), the trajectory is clear.

If your retention strategy relies on making it hard for patients to leave, you are fighting gravity. The winning strategy in a TEFCA world is Service-Level Stickiness. You must be so good that patients choose to keep their data with you, even when they can move it with a click.

Conclusion: From Owner to Steward

The next wave of digital transformation in U.S. healthcare won’t be won by the company with the biggest database. It will be won by the company that generates the most high-fidelity insights from the data it has access to.

Access depends on trust. And trust depends on agency.

Leaders must stop viewing data ownership as a territory to be defended and start viewing it as a relationship to be managed. We must shift from being “Owners” of the record to being “Stewards” of the patient’s digital life to to lead in the next phase of U.S. healthcare.

Common FAQs Around Patient Data in U.S. Healthcare

Who owns medical records in the US?

Legally, the physical or digital medical record is owned by the healthcare provider (hospital or physician) who created it. However, the information inside the record belongs to the patient, who has rights to access and copy it under HIPAA.

Can healthcare providers sell patient data?

In many cases, yes, if the data is “de-identified” (stripped of 18 specific identifiers under HIPAA). However, selling identifiable data (PHI) usually requires explicit patient authorization. New regulations and ethical frameworks are increasingly challenging the practice of selling de-identified data without patient awareness.

What is the difference between data custody and data ownership?

Custody refers to the responsibility of holding, securing, and maintaining the data (usually the role of the provider or EHR vendor). Ownership implies property rights and control over how the data is used. While providers have custody, patients retain rights (agency) over how their information is disclosed.